NIH discontinues tenofovir vaginal gel in 'VOICE' HIV prevention study

A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational microbicide, was not effective among study participants.

Read the whole article on Physorg

More from Physorg